Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

CPSC · 16232 · published 2016-07-27

CPSC campaign 16232

Hazard

The packaging for the prescription drug is not child-resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if swallowed by children.

Remedy

Consumers should immediately stop using the recalled tablets and contact Novel Laboratories for instructions to receive a full refund.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

Novel Laboratories, of Somerset, N.J.

Zolpidem Tartrate Sublingual tablets

Novel Laboratories, of Somerset, N.J.

UPC 343386761012

Novel Laboratories, of Somerset, N.J.

UPC 343386762019

Brands in this recall

Novel Laboratories, of Somerset, N.J.